<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02416375</url>
  </required_header>
  <id_info>
    <org_study_id>PO1955</org_study_id>
    <nct_id>NCT02416375</nct_id>
  </id_info>
  <brief_title>Home Monitoring to Predict Exacerbation in Cystic Fibrosis</brief_title>
  <acronym>SmartCare</acronym>
  <official_title>A Standardized Multi-centre Analysis of Remote Monitoring in Cystic Fibrosis Adult Patients to Reduce Pulmonary Exacerbations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Papworth Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cystic Fibrosis Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King's College Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Brompton &amp; Harefield</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Leeds Teaching Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Southampton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Microsoft Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Frimley Park Hospital NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospitals Bristol and Weston NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Papworth Hospital NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to establish if it is possible for people with Cystic Fibrosis to monitor a&#xD;
      number of parameters on a daily basis at home which might predict respiratory infections&#xD;
      before they have symptoms and which might also predict treatment failures before this is&#xD;
      obvious with conventional measures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will collect the following clinical information daily: pulse rate and oxygen&#xD;
      saturations, wellness and cough scores, spirometry measurements, physical activity,&#xD;
      temperature, weight and sleep quantity and quality. The patients will also collect daily&#xD;
      sputum samples.&#xD;
&#xD;
      Data will be collected via Bluetooth-enabled devices and transmitted via a Smart-phone to a&#xD;
      secure National Health Service approved web-based site to be analyzed.&#xD;
&#xD;
      The information obtained will allow the investigators to develop a software program that will&#xD;
      identify signals that can predict the onset of a chest infection before symptoms develop.&#xD;
&#xD;
      The investigators will also measure specific substances in sputum to identify changes before,&#xD;
      during and after chest infections. The investigators hope this additional information will&#xD;
      enable them to more accurately predict the onset of chest infections in cystic fibrosis.&#xD;
&#xD;
      The results of this study will determine if it is possible to develop a simple sputum test&#xD;
      for patients to use at home in combination with other home-based assessments of well-being to&#xD;
      provide an early warning system of a chest infection before patients feel unwell.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2015</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Home monitoring possible in adult Cystic Fibrosis patients</measure>
    <time_frame>6 months</time_frame>
    <description>This will be measured by the number of patients recruited into the study and the patients compliance / adherence to the study protocol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Whether daily monitoring can provide early warning of a new chest infection</measure>
    <time_frame>6 months</time_frame>
    <description>Identification of predictive signals for early detection of an acute pulmonary exacerbations and treatment response in patients with cystic fibrosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of a web-based machine learning tool</measure>
    <time_frame>6 months</time_frame>
    <description>Development of a web-based machine learning associated tool to predict acute pulmonary exacerbation and treatment response in patients with cystic fibrosis.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">147</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Observation</arm_group_label>
    <description>Adult Cystic Fibrosis patients</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Daily sputum samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Cystic Fibrosis patients who produce sputum daily and have not had a previous organ&#xD;
        transplant, with a history of at least one pulmoanry exacerbation within the past 12&#xD;
        months.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of Cystic Fibrosis based on genetic testing and/or sweat chloride.&#xD;
&#xD;
          2. Age â‰¥ 18 years of age.&#xD;
&#xD;
          3. A history of at least 1 acute pulmonary exacerbation in the past 12 months.&#xD;
&#xD;
          4. Able to provide written informed consent.&#xD;
&#xD;
          5. Willing and able to produce daily sputum samples.&#xD;
&#xD;
          6. Willing and able to provide daily telemetric measure of several physiological&#xD;
             parameters.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients unable to provide written informed consent&#xD;
&#xD;
          2. Patients unable to produce daily sputum samples&#xD;
&#xD;
          3. Less than 1 infective pulmonary exacerbation in 12 months&#xD;
&#xD;
          4. Lung transplant recipients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andres Floto, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Papworth Hospital NHS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Papworth Hospital NHS Trust</name>
      <address>
        <city>Cambridge</city>
        <state>Cambridgeshire</state>
        <zip>CB23 3RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital NHS Trust</name>
      <address>
        <city>Cambridge</city>
        <zip>CB23 3RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>April 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2015</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Papworth Hospital NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Judy Ryan</investigator_full_name>
    <investigator_title>Research &amp; Database Manager</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

